Liver Diseases  >>  mycophenolate mofetil  >>  Phase 4
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
mycophenolate mofetil / Generic mfg.
NCT00163657: Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C Infection

Completed
4
312
US
Daclizumub, Zenapax, Tacrolimus, Prograf, Cyclosporine, Neoral, MMF, mycophenolate mofetil
Baylor Research Institute, Baylor Health Care System, Emory University, University of Southern California, Mayo Clinic - Scottsdale/Phoenix, Arizona, New York Presbyterian Hospital, Oregon Health and Science University, New York University, University of Cincinnati, University of Alabama at Birmingham, The University of Texas Health Science Center at San Antonio, University of Chicago, University of California, San Francisco, Mayo Clinic - Rochester, Minnesota, Medical University of South Carolina, University of Virginia, Lahey Clinic, University of Medicine and Dentistry of New Jersey, Northwestern Memorial Hospital
End Stage Liver Disease, Hepatitis C
04/06
01/07
NCT00206076: Mycophenolate Mofetil Immunosuppression Without/With Reduced Dose Calcineurin Inhibitor Long After Liver Transplantation

Completed
4
19
US
mycophenolate mofetil
Albert Einstein Healthcare Network, Hoffmann-La Roche
Liver Disease
06/09
06/09
NCT01134952: Study of Sirolimus Versus Mycophenolate Liver Transplant Recipients With Recurrent Hepatitis C Virus (HCV)

Completed
4
11
Canada
Mycophenolate to sirolimus switch, rapamune, rapamycin, mycophenolic mofetil, mycophenolic acid, cellcept
London Health Sciences Centre
Hepatitis C
12/14
12/14

Download Options